CClinicalTrials.gg
Status unknownNCT01995214Updated Nov 26, 2013

Sevoflurane and Propofol Anesthesia on Postoperative Delirium

A Phase 4 interventional study of Propofol and Sevoflurane in General Anesthesia and Geriatric Patient, sponsored by Huazhong University of Science and Technology. Status unknown at 1 site in China. Open to participants aged 60 Years and older. Per ClinicalTrials.gov, last updated 2013-11-26.

Sponsored by Huazhong University of Science and Technology · Phase 4, Interventional, and Prevention

The sponsor has not verified this record recently (last verified Nov 2013), so the status shown — last known as Recruiting — may be out of date.
Phase
Phase 4
Study type
Interventional
Enrollment
500
Allocation
Randomized
Ages
60 Years and older
Sex
All
01

Study summary

Delirium is defined as an acute onset and fluctuating course of mental status change with inattention and an altered level of consciousness. Delirium in the postoperative period can be divided into emergence delirium and postoperative delirium, based on the time of onset (Silverstein et al., 2007).Postanaesthesia delirium is a frequent and potentially serious problem affecting the safety of patients and medical personnel. Clinical studies demonstrated that postoperative delirium is associated with worse outcomes such as prolonged hospital stay, postdischarge institutionalization, and increased mortality (Ely et al., 2004a; Thomason et al., 2005; Robinson et al., 2009). Multiple factors may contribute to the development of postoperative delirium, including patient's medical condition, administration of anesthetics or analgesics and degree of operative stress (Yildizeli et al., 2005; Robinson \& Eiseman, 2008; Deiner \& Silverstein, 2009). Sevoflurane anesthesia have been reported to be associated with more emergence delirium in pediatric patients, when compared with propofol anesthesia. It is not clear if propofol anesthesia will benefit the geriatric patients on postoperative delirium, when compared with sevoflurane anesthesia. We hypothesize that propofol anesthesia will reduce the rate of postoperative delirium by 50% when compared with sevoflurane anesthesia.

02

Conditions studied

  • General Anesthesia
  • Geriatric Patient

Keywords

  • Postoperative delirium
  • Geriatric
  • General anesthesia
  • Propofol
  • Sevoflurane
03

In context

Delirium

1,057 studies on the registry are indexed under Delirium; 238 are open to participants now.

This study's planned enrollment of 500 is above the median of 120 across 599 interventional studies indexed under Delirium.

Browse Delirium studies →

Lead sponsor

Huazhong University of Science and Technology is the lead sponsor of 241 studies on the registry; 60 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
60 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • American Society of Anesthesiologists Physical Status classification (ASA_PS) class I-III
  • Aged 60 years or above
  • Elective major surgery under general anesthesia

Exclusion criteria

Exclusion Criteria:

  • ASA_PS>=IV
  • Aged under 60 yr old
  • Body mass index (BMI) >30
  • Neurologic disease
  • Cardiac surgery and neurologic surgery
  • Anticonvulsant drugs
  • Chronic analgesics intake
  • Participating in the investigation of another study
05

Study design

Phase
Phase 4
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Investigator, Outcomes assessor)
Enrollment
500 participants (estimated)

Study arms

  • Experimental
    P

    Anesthesia maintenance with propofol+remifentanil

    Drug: Propofol

  • Experimental
    S

    Anesthesia maintenance with sevoflurane+remifentanil

    Drug: Sevoflurane

Interventions

  • DrugPropofol

    Anesthesia maintenance with propofol+remifentanil guided by Narcotrend index monitoring.

  • DrugSevoflurane

    Anesthesia maintenance with sevoflurane+remifentanil guided by Narcrotrend index monitoring.

06

What researchers measure

Primary outcomes

  1. Postoperative delirium

    Postoperative delirium was determined by Confusion Assessment Method (CAM) at 24 postoperative hours

    Time frame: at 24 postoperative hours

Secondary outcomes

  1. Length of postanesthesia care unit (PACU) stay

    Length of PACU stay (min)

    Time frame: up to 2 hours after PACU admitting

  2. Hemodynamic parameters

    Hart frequency, systolic blood pressure, diastolic blood pressure

    Time frame: 5min, 10min, 20min, 30min after induction, 5min, 10min, 20min, 30min after skin incision, 5min, 10min, 20min, 30min before incision closure

  3. Incidence of postoperative nausea and vomiting

    Incidence of postoperative nausea and vomiting

    Time frame: 24 postoperative hours

  4. Quality of recovery determined by quality of recovery (QOR-40; maximum score 200) score

    Quality of recovery determined by QOR-40

    Time frame: 1,2,3,7 postoperative days

  5. Postoperative delirium

    Postoperative delirium was determined by CAM every day at 2st, 3st, 7st postoperative days

    Time frame: 2st, 3st, 7st postoperative days

  6. Postoperative Stroke

    Postoperative Stroke will be determined by National Institutes of Health Stroke Scale (NIHSS)

    Time frame: 1st, 2st, 3st, 7st postoperative days

07

Study locations

1 of 1 sites recruiting
  • Tongji Hospital
    Wuhan, Hubei 430030, China
    Recruiting
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 26, 2013, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT01995214
Lead sponsor
Huazhong University of Science and Technology
Responsible party
Wei Mei (Associate Professor, Huazhong University of Science and Technology) — Principal investigator
First posted
Nov 26, 2013
Start date
Jun 2013
Primary completion
Dec 2013 (estimated)
Last update
Nov 26, 2013

Study contacts

Wei Mei, MD., PhD
Contact
wmei@tjh.tjmu.edu.cn
00862783663173
Yuke Tian, MD., PhD.
study chair · Department of Anaesthesiology, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Nov 2013. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion